Hints and tips:
Related Topics
...Winter says that traditional big pharma companies were initially sceptical, and it was smaller US biotech companies – notably Genentech and Centocor (now known as Janssen Biotech) – that worked to develop...
...The acquisition constitutes a change of control and triggers Centocor’s right to terminate,” J&J said....
...They show that Johnson & Johnson, which developed the two drugs through its subsidiary Centocor, can seek mandatory binding arbitration after 20 days’ notice if it considers there to have been a change in...
International Edition